Brian Sargent, D.O. Family Medicine Medicare: Medicare Enrolled Practice Location: 44 S Main St, Randolph, VT 05060 Phone: 802-685-0030 Fax: 802-685-4329 |
Kenneth G Borie, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 44 S Main St, Randolph, VT 05060 Phone: 802-728-2445 Fax: 802-728-2394 |
Robert C Kiess, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 44 S Main St, Randolph, VT 05060 Phone: 802-763-8000 Fax: 802-728-2394 |
Shelly L Gasow, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 44 S Main St, Randolph, VT 05060 Phone: 802-234-9913 Fax: 802-728-2394 |
Mark G. Seymour, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 44 S Main St, Randolph, VT 05060 Phone: 802-234-9913 Fax: 802-728-2394 |
Marcus H Coxon, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 44 S Main St, Randolph, VT 05060 Phone: 802-728-2445 Fax: 802-728-2613 |
Emilija O Florance, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 44 S Main St, Randolph, VT 05060 Phone: 802-728-7000 |
Jeffery Lynn Allyn, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 44 S Main St, Randolph, VT 05060 Phone: 802-728-7000 |
Terry W. Cantlin, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 44 S Main St, Randolph, VT 05060 Phone: 802-234-9913 Fax: 802-728-2394 |
Hank R. Glass, D.C. Family Medicine - Sports Medicine Medicare: Not Enrolled in Medicare Practice Location: 44 S Main St, Randolph, VT 05060 Phone: 802-763-8000 Fax: 802-728-2394 |
News Archive
UT Southwestern Medical Center scientists have gleaned a key cellular mechanism of how the body adjusts glucose levels, an important process that when abnormal can promote diabetes, cancer, and rare genetic diseases.
Results from the first swine-flu vaccine trials taking place in Leicester reveal a strong immune response after just one dose.
Viruses are able to redirect the functioning of cells in order to infect them. Inspired by their mode of action, scientists from the CNRS and Université de Strasbourg have designed a "chemical virus" that can cross the double lipid layer that surrounds cells, and then disintegrate in the intracellular medium in order to release active compounds.
BioAlliance Pharma SA, a Company dedicated to the development of orphan oncology products and supportive care products, has presented the results of the pharmacokinetic and pharmacodynamic study on Sitavig at the 10th EADV spring symposium (European Academy of Dermatology and Venereology) in Cracow (Poland) on May 24, 2013.
› Verified 3 days ago